Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Bacteriophage therapy for the treatment of infections.

Górski A, Miedzybrodzki R, Borysowski J, Weber-Dabrowska B, Lobocka M, Fortuna W, Letkiewicz S, Zimecki M, Filby G.

Curr Opin Investig Drugs. 2009 Aug;10(8):766-74. Review.

PMID:
19649921
2.

[Bacteriophages as antibacterial agents].

Shasha SM, Sharon N, Inbar M.

Harefuah. 2004 Feb;143(2):121-5, 166. Review. Hebrew.

PMID:
15143702
3.

Bacteriophages as therapeutic agents.

Sulakvelidze A, Morris JG Jr.

Ann Med. 2001 Nov;33(8):507-9.

PMID:
11730156
4.

Bacteriophages as twenty-first century antibacterial tools for food and medicine.

Maura D, Debarbieux L.

Appl Microbiol Biotechnol. 2011 May;90(3):851-9. doi: 10.1007/s00253-011-3227-1. Epub 2011 Mar 29.

PMID:
21491205
5.

Bacteriophage therapy: a potential solution for the antibiotic resistance crisis.

Golkar Z, Bagasra O, Pace DG.

J Infect Dev Ctries. 2014 Feb 13;8(2):129-36. doi: 10.3855/jidc.3573. Review.

6.

Bacteriophages: potential treatment for bacterial infections.

Duckworth DH, Gulig PA.

BioDrugs. 2002;16(1):57-62. Review.

PMID:
11909002
7.

Bacteriophages as potential new therapeutics to replace or supplement antibiotics.

Kutateladze M, Adamia R.

Trends Biotechnol. 2010 Dec;28(12):591-5. doi: 10.1016/j.tibtech.2010.08.001. Epub 2010 Aug 31. Review.

PMID:
20810181
8.

Bacteriophage therapy of bacterial infections: an update of our institute's experience.

Weber-Dabrowska B, Mulczyk M, Górski A.

Arch Immunol Ther Exp (Warsz). 2000;48(6):547-51. Review.

PMID:
11197610
9.

Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice.

Vinodkumar CS, Kalsurmath S, Neelagund YF.

Indian J Pathol Microbiol. 2008 Jul-Sep;51(3):360-6.

10.

Bacteriophage endolysins as a novel class of antibacterial agents.

Borysowski J, Weber-Dabrowska B, Górski A.

Exp Biol Med (Maywood). 2006 Apr;231(4):366-77. Review.

PMID:
16565432
11.

Bacteriophage therapy in children: facts and prospects.

Fortuna W, Miedzybrodzki R, Weber-Dabrowska B, Górski A.

Med Sci Monit. 2008 Aug;14(8):RA126-32. Review.

PMID:
18668009
12.
13.

Bacteriophages: an appraisal of their role in the treatment of bacterial infections.

Hanlon GW.

Int J Antimicrob Agents. 2007 Aug;30(2):118-28. Epub 2007 Jun 12. Review.

PMID:
17566713
14.

Call for a dedicated European legal framework for bacteriophage therapy.

Verbeken G, Pirnay JP, Lavigne R, Jennes S, De Vos D, Casteels M, Huys I.

Arch Immunol Ther Exp (Warsz). 2014 Apr;62(2):117-29. doi: 10.1007/s00005-014-0269-y. Epub 2014 Feb 6. Review.

15.

A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens.

Wittebole X, De Roock S, Opal SM.

Virulence. 2014 Jan 1;5(1):226-35. doi: 10.4161/viru.25991. Epub 2013 Aug 13. Review.

16.

Is phage therapy acceptable in the immunocompromised host?

Borysowski J, Górski A.

Int J Infect Dis. 2008 Sep;12(5):466-71. doi: 10.1016/j.ijid.2008.01.006. Epub 2008 Apr 8.

17.

Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens.

Burrowes B, Harper DR, Anderson J, McConville M, Enright MC.

Expert Rev Anti Infect Ther. 2011 Sep;9(9):775-85. doi: 10.1586/eri.11.90. Review.

PMID:
21905786
18.

[New perspectives of the phage therapy].

Eyer L, Pantůcek R, Růzicková V, Doskar J.

Klin Mikrobiol Infekc Lek. 2007 Dec;13(6):231-5. Review. Czech.

PMID:
18320502
19.

Antibacterial bioagents based on principles of bacteriophage biology: an overview.

Knoll BM, Mylonakis E.

Clin Infect Dis. 2014 Feb;58(4):528-34. doi: 10.1093/cid/cit771. Epub 2013 Nov 23. Review.

20.

Bacteriophage therapy: an alternative to conventional antibiotics.

Mathur MD, Vidhani S, Mehndiratta PL.

J Assoc Physicians India. 2003 Jun;51:593-6. Review.

PMID:
15266928
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk